| |
| Issue |
Title |
| |
| No 6 (2024) |
Metabolic background as the basis for comorbidity in patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
|
T. Yu. Demidova, F. O. Ushanova |
| |
| No 6 (2024) |
Evaluation of urate-lowering efficacy of isolated and combined use of febuxostat and empagliflozin in patients with gout and type 2 diabetes mellitus (OPORA Clinical Trial) |
Abstract
PDF (Rus)
|
|
V. V. Salukhov, V. I. Mazurov, I. I. Novikov, A. A. Minakov, D. M. Reut, R. A. Bashkinov |
| |
| No 6 (2024) |
Cardiovascular disease and sleep apnea in patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
|
O. M. Koteshkova, M. B. Antsiferov, D. M. Antsiferova, Yu. V. Golubeva, N. A. Demidov |
| |
| No 6 (2024) |
Heart failure phenotypes and clinical and laboratory features of patients with type 2 diabetes in inpatient endocrinology and cardiology practice |
Abstract
PDF (Rus)
|
|
T. Yu. Demidova, M. Ya. Izmaylova |
| |
| No 6 (2024) |
Post-COVID syndrome in patients with type 2 diabetes: definition, epidemiology, pathophysiology, biomarkers and genetic associations |
Abstract
PDF (Rus)
|
|
S. A. Sukhanov, Yu. A. Sorokina, O. V. Zanozina |
| |
| No 6 (2024) |
Non-alcoholic fatty liver disease: a current challenge of interdisciplinary research |
Abstract
PDF (Rus)
|
|
E. V. Biryukova |
| |
| No 9 (2023) |
Rational choice of therapy in patients with diabetes mellitus type 2 with concomitant gout |
Abstract
PDF (Rus)
|
|
T. S. Panevin, V. V. Salukhov, D. M. Reut |
| |
| No 7 (2021) |
Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis |
Abstract
PDF (Rus)
|
|
S. N. Shilov, E. N. Berezikova, A. A. Popova, E. N. Samsonova, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, A. V. Molokov, I. V. Yakovleva |
| |
| No 7 (2021) |
Diabetes mellitus and osteoporosis: pathogenetic relationship and current principles of treatment |
Abstract
PDF (Rus)
|
|
T. Y. Demidova, V. M. Plakhotnyaya |
| |
| No 7 (2021) |
Leptin and its receptor gene polymorphism as a target for pharmacotherapy in T2DM and COPD |
Abstract
PDF (Rus)
|
|
Yu. A. Sorokina, O. V. Zanozina, E. V. Makarova, S. G. Salcev, G. N. Varvarina, L. V. Lovtsova |
| |
| 1 - 10 of 10 Items |
|
